DivcoWest Welcomes Cerevel Therapeutics to Cambridge Crossing

Cambridge, MA, (Aug 07, 2019) – DivcoWest announced today that it has signed a 59,865 square-foot lease with Cerevel Therapeutics at Cambridge Crossing (CX), the new and connected neighborhood at the intersection of Cambridge, Somerville, and Boston. Dedicated to bringing cutting-edge solutions to individuals impacted by nervous system diseases, the bio-pharmaceutical company will join Philips North America at 222 Jacobs Street in 2020, making it the third fully leased commercial building at CX.

READ PRESS RELEASE

Events

Learn more about our events on our Facebook page

News

  • CX Honored with CBA’s Life Science Deal of the Year Award

    Cambridge Crossing //
  • Henri Matisse’s grandson inspired these Cambridge musical fences

    Boston.com // 02.26.19
  • Local Artist Brings Interactive Art & Sound Sculpture to Cambridge Crossing

    Cambridge Crossing // 02.06.19
  • Sanofi signs megalease at Cambridge Crossing

    Boston Globe // 12.17.18
  • Cambridge Crossing developer aims for top web-connectivity rating

    Boston Business Journal // 11.02.18
  • CX Announces Art Installation in Partnership with Community Art Center

    Cambridge Crossing // 10.03.18
  • How Shawmut is Building the Heartbeat of Cambridge Crossing—The New Gateway to Kendall Square

    Shawmut // 08.20.18
  • Green Line extension breaks ground

    Boston Globe // 06.25.18
  • Final Beam Raised at 250 North Street for Philips’ North American HQ

    Boston Business Journal // 06.22.18
  • Philips will move North American HQ to Cambridge — along with 2,000 workers

    Boston Business Journal // 01.12.18